ANA-positive <i>versus</i> ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (“Registry”)
Irene Cecchi(Ospedale San Giovanni Bosco), Savino Sciascia(Ospedale San Giovanni Bosco), Guilherme Ramires de Jesús(Universidade do Estado do Rio de Janeiro), Vittorio Pengo(University of Padua), Maria Efthymiou(University College London), María Laura Bertolaccini(St Thomas' Hospital), Bahar Artım-Esen(Istanbul University), Ricard Cervera(Hospital Clínic de Barcelona), Cecilia Nalli(University of Brescia), Lanlan Ji(Peking University), Massimo Radin(Ospedale San Giovanni Bosco), H. Michael Belmont(New York University), Rohan Willis(The University of Texas Medical Branch at Galveston), Alice Barinotti(Centre for Biomedical Network Research on Rare Diseases), C. López-Pedrera(Instituto Maimónides de Investigación Biomédica de Córdoba), D. Ware Branch(University of Utah), Hannah Cohen(University College London Hospitals NHS Foundation Trust), Silvia Grazietta Foddai(Centre for Biomedical Network Research on Rare Diseases), Maria Gerosa(Istituto Ortopedico Gaetano Pini), Maria G. Tektonidou(National and Kapodistrian University of Athens), Paul R. Fortin(Centre hospitalier de l'Université Laval), Tatsuya Atsumi(Hokkaido University), Jason S. Knight(University of Michigan), Danieli Andrade(Universidade de São Paulo), Doruk Erkan(Hospital for Special Surgery), Esther Rodríguez-Almaraz(Hospital Universitario 12 De Octubre), Michelle Petri(Johns Hopkins University), Guillermo Ruiz‐Irastorza(BioCruces Health research Institute)
Cited by 9
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726
A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis
|Arthritis & Rheumatism|2002|574